Scott Schoenhaus
Stock Analyst at KeyBanc
(0.12)
# 4,484
Out of 4,574 analysts
201
Total ratings
35%
Success rate
-10.2%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintained: Buy | $28 → $35 | $31.19 | +12.22% | 14 | Jul 13, 2026 | |
| HNGE Hinge Health | Maintained: Buy | $90 → $125 | $74.31 | +68.21% | 5 | Jul 13, 2026 | |
| WAY Waystar Holding | Initiated Coverage: Buy | $30 | $22.51 | +33.27% | 1 | Jul 1, 2026 | |
| ODD Oddity Tech | Downgraded: Hold | n/a | $15.34 | - | 10 | Jun 2, 2026 | |
| HQY HealthEquity | Maintained: Buy | $125 | $94.64 | +32.09% | 16 | May 26, 2026 | |
| DOCS Doximity | Maintained: Hold | n/a | $20.42 | - | 12 | May 14, 2026 | |
| ZTS Zoetis | Maintained: Hold | n/a | $75.35 | - | 1 | May 8, 2026 | |
| OMCL Omnicell | Rated: Buy | $60 → $70 | $41.00 | +70.73% | 15 | Apr 29, 2026 | |
| PHR Phreesia | Rated: Buy | $32 → $12 | $10.22 | +17.42% | 14 | Apr 13, 2026 | |
| SDGR Schrödinger | Rated: Buy | $25 → $20 | $14.97 | +33.60% | 11 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $8 | $7.51 | +6.52% | 9 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.71 | - | 8 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.21 | - | 1 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.77 | - | 5 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $29 | $24.91 | +16.42% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.87 | - | 11 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.08 | - | 7 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.96 | - | 10 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $186.24 | - | 17 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $18.34 | - | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $5 | $5.31 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $9 | $7.56 | n/a | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $10.90 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $2.96 | n/a | 7 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $5.14 | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $175 → $250 | $208.05 | n/a | 3 | Apr 16, 2021 |
Progyny
Jul 13, 2026
Maintained: Buy
Price Target: $28 → $35
Current: $31.19
Upside: +12.22%
Hinge Health
Jul 13, 2026
Maintained: Buy
Price Target: $90 → $125
Current: $74.31
Upside: +68.21%
Waystar Holding
Jul 1, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $22.51
Upside: +33.27%
Oddity Tech
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $15.34
Upside: -
HealthEquity
May 26, 2026
Maintained: Buy
Price Target: $125
Current: $94.64
Upside: +32.09%
Doximity
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $20.42
Upside: -
Zoetis
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $75.35
Upside: -
Omnicell
Apr 29, 2026
Rated: Buy
Price Target: $60 → $70
Current: $41.00
Upside: +70.73%
Phreesia
Apr 13, 2026
Rated: Buy
Price Target: $32 → $12
Current: $10.22
Upside: +17.42%
Schrödinger
Apr 13, 2026
Rated: Buy
Price Target: $25 → $20
Current: $14.97
Upside: +33.60%
Apr 13, 2026
Rated: Buy
Price Target: $10 → $8
Current: $7.51
Upside: +6.52%
Mar 11, 2026
Maintained: Buy
Price Target: n/a
Current: $3.71
Upside: -
Mar 10, 2026
Maintained: Hold
Price Target: n/a
Current: $5.21
Upside: -
Feb 27, 2026
Maintained: Hold
Price Target: n/a
Current: $8.77
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: $27 → $29
Current: $24.91
Upside: +16.42%
Feb 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $18.87
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $2.08
Upside: -
Jan 8, 2026
Rated: Hold
Price Target: n/a
Current: $2.96
Upside: -
Dec 12, 2025
Downgraded: Hold
Price Target: n/a
Current: $186.24
Upside: -
Oct 29, 2025
Maintained: Hold
Price Target: n/a
Current: $18.34
Upside: -
Apr 16, 2025
Maintained: Buy
Price Target: $4 → $5
Current: $5.31
Upside: n/a
Apr 16, 2025
Maintained: Buy
Price Target: $5 → $9
Current: $7.56
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: $9
Current: $10.90
Upside: n/a
Jan 8, 2025
Maintained: Buy
Price Target: $12 → $10
Current: $2.96
Upside: n/a
Sep 15, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $5.14
Upside: n/a
Apr 16, 2021
Upgraded: Buy
Price Target: $175 → $250
Current: $208.05
Upside: n/a